Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 14, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Is endoscopic third ventriculostomy an internal shunt alone?

M Gangemi1, F Maiuri, G Colella

  • 1Department of Neurological Sciences, Section of Neurosurgery, Federico II University School of Medicine, Naples, Italy. mgangemi@unina.it

Minimally Invasive Neurosurgery : MIN
|June 5, 2007
PubMed
Summary

Endoscopic third ventriculostomy (ETV) effectively treats hydrocephalus by restoring cerebrospinal fluid (CSF) flow. This procedure enhances brain pulsatility, normalizing CSF dynamics and reducing the need for shunts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.

United European gastroenterology journal·2024
Same author

ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology.

Journal of Crohn's & colitis·2022
Same author

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.

Journal of Crohn's & colitis·2021
Same author

Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce.

Journal of Crohn's & colitis·2020
Same author

Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease - A systematic review and meta-analysis: <b>PS083</b>.

Porto biomedical journal·2020
Same author

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.

Journal of Crohn's & colitis·2019

Area of Science:

  • Neurosurgery
  • Neurology
  • Pediatric Neurosurgery

Background:

  • Hydrocephalus is a condition characterized by abnormal accumulation of cerebrospinal fluid (CSF) within the brain's ventricles.
  • Endoscopic third ventriculostomy (ETV) is a neurosurgical procedure used to treat certain types of hydrocephalus.
  • Understanding the precise mechanism of ETV is crucial for optimizing treatment outcomes.

Purpose of the Study:

  • To elucidate the mechanism of endoscopic third ventriculostomy (ETV) across diverse hydrocephalus etiologies.
  • To correlate intraoperative findings with ETV success rates in different hydrocephalus patient groups.

Main Methods:

  • Retrospective review of 140 patients with hydrocephalus treated with ETV.
  • Classification of patients into three groups: obstructive hydrocephalus, post-infection/hemorrhage hydrocephalus, and idiopathic normal pressure hydrocephalus.

More Related Videos

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Related Experiment Videos

Last Updated: Jul 14, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

  • Analysis of hydrocephalus type, etiology, intraoperative third ventricular floor mobility, patient outcomes, and shunt-independence rates.

    • Main Results:

    • Overall ETV success rate was 79.3% (111/140 shunt-free patients).
    • Success rates varied by group: 88% for obstructive hydrocephalus, 60% for post-infection/hemorrhage, and 73.4% for idiopathic normal pressure hydrocephalus.
    • Significant third ventricular floor mobility observed in 86.4% of cases post-ETV, particularly in obstructive hydrocephalus.

    Conclusions:

    • ETV success in various hydrocephalus forms, coupled with observed third ventricular floor mobility, suggests a primary mechanism of restoring ventricular wall pulsatility.
    • This restoration facilitates CSF flow into subarachnoid spaces, normalizing CSF dynamics.
    • ETV functions not merely as an internal shunt but fundamentally enhances the brain's intrinsic pulsatility for CSF circulation.